Endocrinologic and Metabolic Drugs Advisory Committee The Inn and Conference Center, University of Maryland University College Adelphi, MD September 16, 2010(VOTING MEMBERS OF FDA ADVISORY COMMITTEE FOR ARNA)
VOTED (5 YES - 9 NO)
NO = Heidi M. Connolly, M.D. = https://forms.mayoforms.org/forms/up/friend.cfm
NO = Pamela S. Douglas M.D., M.A.C.C., F.A.S.E. = Office Telephone = 919-681-2690
NO = Eric I. Felner, M.D. = Office Telephone = 404-778-2400
YES = Allison B. Goldfine, M.D. = Office Telephone = 617-732-2400
NO = Sanjay Kaul, M.D. = Office Telephone = 310-423-4876 Kaul@cshs.org jsegal@jhmi.edu
YES = Jodi B. Segal, M.D., M.P.H. = jsegal@jhmi.edu
YES = Abraham Thomas, M.D., M.P.H. =Telephone = 313-916-3761 athomas3@hfhs.org
NO = Lamont G. Weide M.D., Ph.D., F.A.C.E. = Telephone = 816-404-4070 lamont.weide@tmcmed.org
YES = Melanie Coffin = melanie.coffin@montgomerycountymd.gov
NO = Katherine M. Flegal, Ph.D. = katherine.flegal@cdc.hhs.gov
NO = Jacqueline S. Gardner, Ph.D., M.P.H. = jsgardne@uw.edu
NO = Edward W. Gregg, Ph.D. = edward.gregg@cdc.hhs.gov
NO = Jessica W. Henderson, Ph.D. = Henderson@WOU.EDU
YES = Michael A. Proschan, Ph.D. = Michael.Proschan@nih.hhs.gov
FOR THE COMPLETE INDIVIDUAL ADDRESS OF ALL OF THESE PANEL VOTERS:
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225627.pdf
FOR THE ACTUAL VOTES MADE BY EACH VOTING ARNA PANEL MEMBER: http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_A/threadview?m=tm&bn=1339&tid=144437&mid=144449&tof=-1&rt=2&frt=2&off=1
Tuesday, October 12, 2010
Wednesday, September 22, 2010
FDA Pulled A Major Shocker On Arena Lorqess
1. As a medical doctor, I concur with the views of James Hill, M.D. in his interpretation of what FDA just did to the potential obesity tool called Lorqess of Arena Pharmaceuticals.
Interesting reading at: http://seekingalpha.com/instablog/398853-james-hill-md/94978-fda-panel-flubbed-in-arenas-lorcaserin-disapproval
2. A Breast Surgeon from Houston has similar interpretation: http://www.investorvillage.com/smbd.asp?mb=633&mn=6708&pt=msg&mid=9540066 And
http://www.investorvillage.com/smbd.asp?mb=633&mn=6707&pt=msg&mid=9540065
3. Another medical doctor from UCLA has important data about the subject:
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_A/threadview?m=tm&bn=1339&tid=128421&mid=128421&tof=2&frt=2
4. BLOG SITE OF ARENA INVESTORS: http://arenadeepcapture.blogspot.com
5. ARENA PHARMACEUTICAL WEBSITE: http://www.arenapharm.com/
Follow the coming developments of this much needed tool for Obesity.
Interesting reading at: http://seekingalpha.com/instablog/398853-james-hill-md/94978-fda-panel-flubbed-in-arenas-lorcaserin-disapproval
2. A Breast Surgeon from Houston has similar interpretation: http://www.investorvillage.com/smbd.asp?mb=633&mn=6708&pt=msg&mid=9540066 And
http://www.investorvillage.com/smbd.asp?mb=633&mn=6707&pt=msg&mid=9540065
3. Another medical doctor from UCLA has important data about the subject:
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_A/threadview?m=tm&bn=1339&tid=128421&mid=128421&tof=2&frt=2
4. BLOG SITE OF ARENA INVESTORS: http://arenadeepcapture.blogspot.com
5. ARENA PHARMACEUTICAL WEBSITE: http://www.arenapharm.com/
Follow the coming developments of this much needed tool for Obesity.
Subscribe to:
Posts (Atom)